(Total Views: 575)
Posted On: 01/06/2021 11:03:32 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: MD VIROLOGIST #71626
I'd pay for it
But in all seriousness, do you have thoughts on the effectiveness of the two drugs in comparison? If leronlimab has a higher receptor occupancy will it work quicker/better/more effectively? I know Dr. Patterson has encouraged looking at RO in our trials but I am not sure I understand why in a disease like COVID as opposed to HIV so any insight is honestly appreciated.
![;-) ;-)](smileys/wink.gif)
But in all seriousness, do you have thoughts on the effectiveness of the two drugs in comparison? If leronlimab has a higher receptor occupancy will it work quicker/better/more effectively? I know Dr. Patterson has encouraged looking at RO in our trials but I am not sure I understand why in a disease like COVID as opposed to HIV so any insight is honestly appreciated.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)